What does CUSIP 71678J100 represent in this 13F holders report?

CUSIP 71678J100 is the security identifier for PTPI - PETROS PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held PTPI - PETROS PHARMACEUTICALS INC - COM in Q3 2022?

9 institutional investors reported PTPI - PETROS PHARMACEUTICALS INC - COM for Q3 2022. Use the holders table for investor-level position and value details.

PETROS PHARMACEUTICALS INC - COM (PTPI)

CUSIP: 71678J100

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / COM
Total 13F shares: 692,432
Total 13F value: $354,000
Share change: +20,462
Put/Call ratio: 361%
SEC-reported price per share: $0.51
Number of holders: 9
Value change: -$17,389
Number of buys: 4
Number of sells: 4

Security key

71678J100

Report period

Q3 2022

Institutions

Top holders

PTPI full security history Ownership snapshot Full 13F holder table Petros Pharmaceuticals, Inc. SEC filings Petros Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PTPI - PETROS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

John D. Shulman

Disclosed value leader

John D. Shulman

Comparable rows

0/14

Latest evidence

30 Jun 2022

3/4/5 13F Highest disclosed value: $19,563,156 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

John D. Shulman has the largest disclosed position value at $19.56M.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens John D. Shulman's linked filing trail.

Disclosed position value Top 5

John D. Shulman $19.56M

BlackRock Finance, Inc. $139K

VANGUARD GROUP INC $100K

SUSQUEHANNA INTERNATIONAL GROUP, LLP $75K

GEODE CAPITAL MANAGEMENT, LLC $61K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
John D. Shulman	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	$19,563,156 5,812,873 shares mixed-class rows	—	22 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$139,000 165,095 shares	—	30 Jun 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$100,000 119,141 shares	—	30 Jun 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	— denominator unverified	$75,000 90,517 shares	—	30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$61,000 75,367 shares	—	30 Jun 2022
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$59,000 71,391 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

692,432

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

-3

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %